Glenmark gets USFDA nod for contraceptive tablets
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Loestrin tablets used to prevent pregnancy. Glenmark Pharmaceuticals USA has been granted... Press Release / Media Release
Dear Sirs, Sub: Glenmark Pharmaceuticals receives ANDA approval for HAILEYTM 24 Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets), 1 mg/20 mcg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.... Glenmark Pharma launches nicotine substitute gum Kwitz
Kwitz nicotine gum will be available in two variants of 2 mg as an OTC product 4mg as prescription product, the company said in a statement New launches near-term triggers for Glenmark
Risk-reward remains favourable as current tepid growth is factored in Glenmark Pharma shares plunge 3%
Shares of Glenmark Pharmaceuticals Ltd fell as much as 3 per cent in its biggest intraday percentage drop in over a month on lower net profit. The company had on Thursday reported a 4.2 per cent... Appointment of Chief Financial Officer (CFO)
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board at its Meeting held on November 2, 2017 have approved the appointment of Mr. V. S. Mani as President & Global Chief Financial Officer with effect from November 16, 2017 upon the recommendation of the Nomination and Remuneration Committee. Mr. P Ganesh, current President and Global Chief... Allotment of ESOP / ESPS
We have to inform that the Nomination & Remuneration Committee of the Company, at its meeting held on November 2, 2017 has allotted 25,306 stock options pursuant to Employee Stock Options Scheme, 2016. Outcome Of The Board Meeting - November 2, 2017
Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR, 2015') Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2017.... Analyst / Investor Meet - Intimation
Enclosed please find herewith the details of Earnings Call slated for Friday, November 3, 2017 at 08:30 a.m. - 09:30 a.m. (IST), for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call. Glenmark launches oral drug for Psoriasis treatment
Glenmark Pharmaceuticals has launched Apremilast, the first advanced oral systemic treatment for Psoriasis in India. Apremilast, which is a phosphodiesterase 4 (PDE4) inhibitor indicated for the...